These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16363555)

  • 1. [Cap polyposis and Helicobacter pylori].
    Nishiyama M; Maeda K; Aoyagi K; Sakisaka S
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():328-30. PubMed ID: 16363555
    [No Abstract]   [Full Text] [Related]  

  • 2. [Guidelines in the management of H. pylori infection in Japan].
    Asaka M
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():12-6. PubMed ID: 16363496
    [No Abstract]   [Full Text] [Related]  

  • 3. [Triple therapy for eradication of Helicobacter pylori in Japan].
    Takeda H
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():409-13. PubMed ID: 16363569
    [No Abstract]   [Full Text] [Related]  

  • 4. [Adverse effects of Helicobacter pylori eradication and its prevention].
    Zhang S; Yanaka A
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():414-7. PubMed ID: 16363570
    [No Abstract]   [Full Text] [Related]  

  • 5. [Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication].
    Mitsuno Y; Yoshida H
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():452-4. PubMed ID: 11979826
    [No Abstract]   [Full Text] [Related]  

  • 6. [Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment].
    Tsukada K; Katoh H; Miyazaki T; Kuwano H
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():486-8. PubMed ID: 16363585
    [No Abstract]   [Full Text] [Related]  

  • 7. [Helicobacter pylori eradication therapy for children].
    Konno M
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():470-3. PubMed ID: 16363581
    [No Abstract]   [Full Text] [Related]  

  • 8. [Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?].
    Nagahara A; Sato N
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():421-5. PubMed ID: 16363572
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cetraxate hydrochloride (Neuer) induces the effectiveness of new triple therapy in H. pylori eradication].
    Oka M; Ichinose M; Fujishiro M; Omata M
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():461-4. PubMed ID: 16363579
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ecabet sodium (ECA) + PPI + AMPC therapy for clarithromycin-resistant Helicobacter pylori infections].
    Kagaya H; Kato M; Asaka M
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():455-9. PubMed ID: 11979827
    [No Abstract]   [Full Text] [Related]  

  • 11. [Peptic ulcer in the elderly].
    Watanabe T; Chiba T
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():603-7. PubMed ID: 11979855
    [No Abstract]   [Full Text] [Related]  

  • 12. [H. pylori eradication package set (Lansap)].
    Kawai T; Kawakami K; Moriyasu F; Takagi Y
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():361-5. PubMed ID: 16363560
    [No Abstract]   [Full Text] [Related]  

  • 13. [Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection].
    Inoue K; Sugano K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():460-4. PubMed ID: 11979828
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison between one-week and two-week regimens of new triple therapy in H. pylori eradication].
    Kobayashi K; Fujishiro M; Omata M; Oka M
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():459-60. PubMed ID: 16363578
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura.
    Tsutsumi Y; Kanamori H; Yamato H; Ehira N; Kawamura T; Umehara S; Mori A; Obara S; Ogura N; Tanaka J; Asaka M; Imamura M; Masauzi N
    Ann Hematol; 2005 Nov; 84(12):807-11. PubMed ID: 16078036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Four kinds of new triple therapy regiments for Helicobacter pylori eradication in patients with peptic ulcer].
    Shirai T; Kurumada T; Kouda K; Watanabe S; Tada U; Wada T; Takagi A; Harasawa S; Miwa T
    Nihon Rinsho; 1999 Jan; 57(1):140-3. PubMed ID: 10036951
    [No Abstract]   [Full Text] [Related]  

  • 17. Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
    Fennerty MB
    Am J Gastroenterol; 1998 Jan; 93(1):2-3. PubMed ID: 9448162
    [No Abstract]   [Full Text] [Related]  

  • 18. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
    Lara LF; Cisneros G; Gurney M; Van Ness M; Jarjoura D; Moauro B; Polen A; Rutecki G; Whittier F
    Arch Intern Med; 2003 Sep; 163(17):2079-84. PubMed ID: 14504122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PPI plus bismuth-based quintuple therapy].
    Kimura K; Hiratsuka T; Tamura K; Hiratsuka H; Suzuki T; Bray R
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():452-8. PubMed ID: 16363577
    [No Abstract]   [Full Text] [Related]  

  • 20. [Guidelines in the management of Helicobacter pylori infection in Japan].
    Asaka M
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():703-8. PubMed ID: 12722304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.